Literature DB >> 1905303

T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis.

S Raziuddin1, S Shetty, A Ibrahim.   

Abstract

Patients with schistosomiasis of the urinary bladder (SB) and schistosomiasis with carcinoma of the urinary bladder (SCB) had significantly increased percentage of IL-2R-, HLA-DR-, and transferrin receptor (T9)-bearing T cells in circulation. The percentage of these activated T cells decreased by in vitro culture with PHA but increased by Schistosoma haematobium soluble egg antigen. These patients with SB and SCB had a PHA-specific defect in IL-2 production. A functional defect with induction of IL-2R-positive suppressor monocytes appears to correlate with the defective PHA-induced IL-2 production by CD4+ T cells and monocytes. Disordered regulation of PHA-induced IL-2 production by the CD4+ T cells and monocytes may be the key feature in the highly depressed cell-mediated immune response in schistosomiasis. However, immune activation and significantly elevated IL-2 production in response to disease-specific S. haematobium soluble egg antigen may be related with the pathogenesis of SB and SCB. Thus, S. haematobium-specific CD4+ T cells are present in schistosomiasis, and their function is determined by adequate release of IL-2-and/or IL-2R-bearing CD11+ suppressor monocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905303     DOI: 10.1007/bf00917746

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  33 in total

Review 1.  Hepatosplenic schistosomiasis mansoni: an immunologic disease.

Authors:  K S Warren
Journal:  Bull N Y Acad Med       Date:  1975-04

2.  Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative responses to parasite antigens.

Authors:  E A Ottesen
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

4.  Decreased human IL-2 receptor expression due to a protozoan pathogen.

Authors:  F Kierszenbaum; M B Sztein; L A Beltz
Journal:  Immunol Today       Date:  1989-04

5.  Recombinant interferon-gamma induces interleukin 2 receptors on human peripheral blood monocytes.

Authors:  W Holter; R Grunow; H Stockinger; W Knapp
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

6.  The association between Schistosoma haematobium infection and heavy proteinuria.

Authors:  E Ezzat; R A Osman; K Y Ahmet; J F Soothill
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

Review 7.  The adoptive immunotherapy of cancer using the transfer of activated lymphoid cells and interleukin-2.

Authors:  S A Rosenberg
Journal:  Semin Oncol       Date:  1986-06       Impact factor: 4.929

Review 8.  Games parasites play: how parasites evade immune surveillance.

Authors:  B R Bloom
Journal:  Nature       Date:  1979-05-03       Impact factor: 49.962

9.  Suppression splenic T lymphocytes in human hepatosplenic Schistosomiasis mansoni.

Authors:  J J Ellner; G R Olds; R Kamel; G S Osman; A el-Kholy; A A Mahmoud
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

10.  Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.

Authors:  A Harel-Bellan; M Joskowicz; D Fradelizi; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  3 in total

Review 1.  Unusual infections in humans.

Authors:  R C Neafie; A M Marty
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

2.  Tumor necrosis factor alpha production in schistosomiasis with carcinoma of urinary bladder.

Authors:  S Raziuddin; M Masihuzzaman; S Shetty; A Ibrahim
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

Review 3.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.